MedPath

Runzaoyin in the treatment of primary Sjogren's syndrome Clinical observation of spleen deficiency and fluid deficiency syndrome

Not Applicable
Conditions
primary Sjogren's syndrome
Registration Number
ITMCTR2200005628
Lead Sponsor
Xiyuan Hospital, Chinese Academy of traditional Chinese medical science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? Meet the classification criteria of ACR and EULAR primary Sjogren's syndrome in 2016; ? Spleen deficiency and fluid deficiency syndrome conforming to the standard of TCM syndrome differentiation; ? Age 18-70 years; ? Informed and signed informed consent.

Exclusion Criteria

? It belongs to secondary Sjogren's syndrome complicated with other connective tissue diseases (such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, etc.); ? Women with family planning during pregnancy, lactation or observation; ? Allergic constitution or allergic to the drug components of the preparation; ? Patients with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system; ? Suspected history of alcohol and drug abuse, or other situations that reduce the possibility of enrollment or complicate enrollment according to the judgment of the researcher, such as frequent changes in the working environment, which is easy to cause loss of follow-up; ? Subjects who have participated or are participating in clinical trials of other drugs within 4 weeks.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ESSPRI;
Secondary Outcome Measures
NameTimeMethod
TCM syndrome score;Exocrine gland function index;Laboratory indicators(IgA\G\M,C3\C4,ESR,CRP,RF,IL6);ESSDAI;
© Copyright 2025. All Rights Reserved by MedPath